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Introduction:  Current CF infection control guidelines suggest that a distance 
of <1 metre between patients is associated with an increased risk of  
cross-infection. 
Aims:  In this study we sought to determine in adults with CF: i) the distance 
that cough aerosol particles containing viable Pa can travel,  
and ii) the duration that Pa survives in cough aerosol particles. 
Methods:  This investigation involved 9 adults with CF (8 with chronic Pa 
infection) and 5 age-matched healthy volunteers.  Each subject performed a 
series of voluntary coughs into two cough aerosol sampling systems to enable 
size fractioning of aerosol particles and culture of viable Pa at 3 distances (1, 2 
and 4 metres), and after 3 ageing durations (5, 15 and 45 minutes). 
Results:  Pa was isolated in cough aerosols from 100% of chronically infected 
CF patients.  The majority of viable aerosols consisted of particles that were in 
the respirable size range (≤3.3 microns diameter).  Viable Pa was isolated at 1, 
2 and 4 metres, and after 5, 15 and 45 minutes from 7 and 5 patients, 
respectively. 
Conclusions:  During coughing, patients with CF produce aerosols containing 
viable Pa that are capable of persisting over distance and time, suggesting the 
potential for airborne transmission at >1 metre and for prolonged periods. 
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